How we create value

We are focused on maximising value at all points of the investment cycle to deliver transformational treatments to patients, capture superior risk adjusted returns for shareholders and build long term value for all stakeholders.

To build our dynamic portfolio of globally leading healthcare businesses, we found, build and fund companies around exceptional science. In doing so we seek to capture the out-return that comes from commercialising life science.

We take a long-term approach and focus on maximising value through the cycle. Our fundamental view is that value creation in life science comes by taking products into late development, product approval and in some cases beyond. We focus on building companies which can achieve this, ideally with multiple products. Our capital pool ensures we have control over and flexibility to manage our portfolio as we seek to maximise returns over the long term.